Order of the President of the General Court of 26 September 2019 — Medac Gesellschaft für klinische Spezialpräparate v Commission

(Case T-549/19 R)

(Application for interim measures - Orphan medicinal product - Application to suspend operation of a measure - No urgency)

(2020/C 19/64)

Language of the case: German

Parties

Applicant: Medac Gesellschaft für klinische Spezialpräparate mbH (Wedel, Germany) (represented by: P. von Czettritz, lawyer)

Defendant: European Commission (represented by: J. F. Brakeland, L. Haasbeek and C. Hermes, acting as Agents)

Re:

Application under Articles 278 and 279 TFEU to suspend the operation of Article 5 of Commission Implementing Decision C (2019) 4858 final of 20 June 2019 granting marketing authorisation under Regulation No 726/2004 of the European Parliament and of the Council for ‘Trecondi-treosulfan’, a medicinal product for human use.

Operative part of the order

The Court orders:

1.	The application for interim measures is refused.

2.	Costs are reserved.